20:29:54 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Beskrivning

LandSverige
ListaMid Cap Stockholm
SektorHälsovård
IndustriMedicinteknik
Elos Medtech är verksamma inom medicinteknik. Bolaget arbetar med forskning och utveckling av produkter och medicintekniska komponenter för dentala- och ortopediska implantat. Verksamheten bedrivs via egna anläggningar runtom Norden, Nordamerika och Asien. Kunderna utgörs huvudsakligen av internationellt verksamma företagskunder. Huvudkontoret ligger i Göteborg.

Kalender

2024-02-22 Bokslutskommuniké 2023
2023-10-19 Kvartalsrapport 2023-Q3
2023-07-14 Kvartalsrapport 2023-Q2
2023-05-03 Årsstämma 2023
2023-04-26 Kvartalsrapport 2023-Q1
2023-02-23 Bokslutskommuniké 2022
2022-10-21 Kvartalsrapport 2022-Q3
2022-08-18 Kvartalsrapport 2022-Q2
2022-05-04 Ordinarie utdelning ELOS B 0.00 SEK
2022-05-03 Årsstämma 2022
2022-04-26 Kvartalsrapport 2022-Q1
2022-02-24 Bokslutskommuniké 2021
2021-12-22 Extra Bolagsstämma 2021
2021-10-20 Kvartalsrapport 2021-Q3
2021-07-16 Kvartalsrapport 2021-Q2
2021-05-04 Ordinarie utdelning ELOS B 1.50 SEK
2021-05-03 Årsstämma 2021
2021-04-28 Kvartalsrapport 2021-Q1
2021-02-24 Bokslutskommuniké 2020
2020-10-20 Kvartalsrapport 2020-Q3
2020-07-16 Kvartalsrapport 2020-Q2
2020-05-05 Kvartalsrapport 2020-Q1
2020-04-22 Ordinarie utdelning ELOS B 0.00 SEK
2020-04-21 Årsstämma 2020
2020-02-18 Bokslutskommuniké 2019
2019-10-24 Kvartalsrapport 2019-Q3
2019-07-18 Kvartalsrapport 2019-Q2
2019-04-24 Ordinarie utdelning ELOS B 1.00 SEK
2019-04-23 Kvartalsrapport 2019-Q1
2019-04-23 Årsstämma 2019
2019-02-18 Bokslutskommuniké 2018
2018-10-25 Kvartalsrapport 2018-Q3
2018-07-19 Kvartalsrapport 2018-Q2
2018-04-25 Ordinarie utdelning ELOS B 0.00 SEK
2018-04-24 Kvartalsrapport 2018-Q1
2018-04-24 Årsstämma 2018
2018-02-19 Bokslutskommuniké 2017
2017-10-24 Kvartalsrapport 2017-Q3
2017-08-25 Kvartalsrapport 2017-Q2
2017-04-27 Ordinarie utdelning ELOS B 1.30 SEK
2017-04-26 Årsstämma 2017
2017-04-26 Kvartalsrapport 2017-Q1
2017-02-24 Bokslutskommuniké 2016
2016-10-26 Kvartalsrapport 2016-Q3
2016-08-24 Kvartalsrapport 2016-Q2
2016-04-27 Ordinarie utdelning ELOS B 1.00 SEK
2016-04-26 Kvartalsrapport 2016-Q1
2016-04-26 Årsstämma 2016
2016-02-25 Bokslutskommuniké 2015
2015-10-23 Kvartalsrapport 2015-Q3
2015-08-21 Kvartalsrapport 2015-Q2
2015-04-28 Ordinarie utdelning ELOS B 2.00 SEK
2015-04-28 Bonusutdelning ELOS B 1
2015-04-27 Kvartalsrapport 2015-Q1
2015-04-27 Årsstämma 2015
2015-02-19 Bokslutskommuniké 2014
2014-10-24 Kvartalsrapport 2014-Q3
2014-08-22 Kvartalsrapport 2014-Q2
2014-04-30 Ordinarie utdelning ELOS B 2.00 SEK
2014-04-29 Kvartalsrapport 2014-Q1
2014-04-29 Årsstämma 2014
2014-02-21 Bokslutskommuniké 2013
2013-10-23 Kvartalsrapport 2013-Q3
2013-08-21 Kvartalsrapport 2013-Q2
2013-04-26 Ordinarie utdelning ELOS B 1.00 SEK
2013-04-25 Årsstämma 2013
2013-04-25 Kvartalsrapport 2013-Q1
2013-02-22 Bokslutskommuniké 2012
2012-10-26 Kvartalsrapport 2012-Q3
2012-08-22 Kvartalsrapport 2012-Q2
2012-04-24 Ordinarie utdelning ELOS B 1.50 SEK
2012-04-23 Årsstämma 2012
2012-04-23 Kvartalsrapport 2012-Q1
2012-02-24 Bokslutskommuniké 2011
2011-10-26 Kvartalsrapport 2011-Q3
2011-08-18 Kvartalsrapport 2011-Q2
2011-05-04 Ordinarie utdelning ELOS B 1.50 SEK
2011-05-03 Årsstämma 2011
2011-05-03 Kvartalsrapport 2011-Q1
2011-02-25 Bokslutskommuniké 2010
2010-10-27 Kvartalsrapport 2010-Q3
2010-08-19 Kvartalsrapport 2010-Q2
2010-04-29 Ordinarie utdelning ELOS B 0.00 SEK
2010-04-28 Kvartalsrapport 2010-Q1
2010-02-25 Bokslutskommuniké 2009
2009-10-23 Kvartalsrapport 2009-Q3
2009-08-20 Kvartalsrapport 2009-Q2
2009-04-30 Ordinarie utdelning ELOS B 1.50 SEK
2009-04-29 Årsstämma 1
2009-04-29 Kvartalsrapport 2009-Q1
2008-04-29 Ordinarie utdelning ELOS B 1.50 SEK
2007-04-26 Ordinarie utdelning ELOS B 0.50 SEK
2006-04-28 Ordinarie utdelning ELOS B 1.25 SEK
2005-05-20 Split ELOS B 1:2
2005-05-04 Ordinarie utdelning ELOS B 2.50 SEK
2004-04-30 Ordinarie utdelning ELOS B 0.00 SEK
2003-05-07 Ordinarie utdelning ELOS B 0.00 SEK
2002-04-26 Ordinarie utdelning ELOS B 0.00 SEK
2001-04-27 Ordinarie utdelning ELOS B 2.25 SEK
1995-06-15 Split ELOS B 1:2
2021-09-27 11:30:00

In accordance with the decision of the 2021 Annual General Meeting the Nomination Committee shall consist of not less than three and not more than five members. In addition, the Chairman of the Board shall be co-opted to the Nomination Committee. Based on the shareholder statistics on 31 August 2021 kept by Euroclear, the Chairman of the Board will offer the three largest shareholders based on the largest voting rights, as well as the shareholder with the largest proportion of equity to appoint members to the Nomination Committee. If the same shareholder is both among the three largest in voting rights and the largest in the capital share, representation takes place only with one participant from the same shareholder, while the shareholder who comes closest in succession to the capital share is offered to be represented in the Nomination Committee. If shareholders waive the right to appoint a member within one week of being contacted by the Chairman of the Board, the right to appoint a member transfer to a shareholder who, in the number of votes and the capital share respectively, comes closest in succession. Called members as above have undertaken to represent the respective shareholders, which has taken place within a week.

In accordance with the decision of the Annual General Meeting of Elos Medtech AB, the following has been appointed a member of the Nomination Committee:
  • Lovisa Lander, appointed by Goldcup 27911 AB (TA Associates)
  • Thomas Öster, appointed by family Öster (incl. companies)
  • Kent Molin, appointed by family Molin
  • Jonas Fridh, appointed by Bank Julius Baer & Co LTD

The Chairman of the Nomination Committee is Lovisa Lander, appointed by the Nomination Committee. The Chairman of the Board, Yvonne Mårtensson, is co-opted to the Nomination Committee.

As of 31 August 2021, the Nomination Committee together represents approximately 97 percent of the voting rights for all voting shares in the company.

The Annual General Meeting of Elos Medtech AB will be held on Tuesday, 3 May 2022.

The Nomination Committee shall submit proposals on the following issues for resolution to the 2022 Annual General Meeting:
  • Election of Chairman of the meeting
  • Number of board members
  • Remuneration to the Board of Directors and Chairman of the Board and remuneration for committee work
  • Election of members and Chairman of the Board
  • Fees to auditor
  • Election of auditor
  • Tasks and principles of the Nomination Committee

The Nomination Committee's proposal will be presented in the notice convening the Annual General Meeting 2022 and on the company's website.

Shareholders who wish to submit proposals to Elos Medtech's Nomination Committee can send an e-mail to valberedning@elosmedtech.comwith the title "To the Nomination Committee" or by mail to Elos Medtech AB, Torsgatan 5B, SE-411 04 Gothenburg, marked "To the Nomination Committee" at the latest 14 January, 2022.

Gothenburg, September 27, 2021

Elos Medtech AB (publ)

 

For more information, please contact Lovisa Lander, Chairman of The Nomination Committee, phone: +44 (0)20 7823 0211 e-mail: llander@ta.com

For additional information about the Elos Medtech Group, visit www.elosmedtech.com